Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler)
Detection, Estimation and Characterization of Pulmonary Blood Pressure by Transthoracic Parametric Doppler (TPD)
Sponsor: Echosense Ltd.
Terminated
Low recruitment
Other terminated trials from Echosense Ltd.
- Pulmonary Hypertension · Jul 2021
- ADHF · Phase NA · Jul 2021
- Pulmonary Embolism · Phase NA · Jan 2019
- Pulmonary Hypertension · Feb 2017
- Pulmonary Hypertension · Phase NA · Dec 2015
More terminations from Echosense Ltd.
Other Pulmonary Arterial Hypertension trials with similar outcome
This PHASE1 trial investigates Pulmonary Arterial Hypertension and is currently terminated or withdrawn. Echosense Ltd. leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Echosense Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .